Back to search

Article

Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells

2023-03-22

Abstract excerpt

<h4>Summary</h4> CRISPR-Cas9 genome editing has enabled advanced T cell therapies, but occasional loss of the targeted chromosome remains a safety concern. To investigate whether Cas9-induced chromosome loss is a universal phenomenon and evaluate its clinical significance, we conducted a systematic analysis in primary human T cells. Arrayed and pooled CRISPR screens revealed that chromosome loss was generalizable...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7eb58ec8-eb32-5597-bd7b-c499adcbbf73
DOI
10.1101/2023.03.22.533709
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cellsDOI 10.1101/2023.03.22.533709
Select a neighboring publication to make it the new centre.